Technological advances in molecular biology have revolutionized the management of cancer patients, and also assisted their relatives in cases of genetic predisposition identification.

Combining isothermal amplification and lateral flow technologies (IA-LFA) creates a powerful diagnostic tool that provides the sensitivity and specificity of isothermal amplification, with the rapid read out results of lateral flow assays.

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. How will these developments shape future strategies in HIV and STI management?

Recent years have witnessed a sea-change in how laboratory tests have been employed to diagnose, monitor, and manage viral infections.

In this webinar, Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service.

Throughout the session, Dr. Dunn will also cover the role of diagnostic stewardship in ensuring patients receive testing with the appropriate diagnostic modality. There are many challenges and opportunities with the integration of molecular microbiology testing in different settings and with proper test selection and utilization, there can be significant benefits in patient outcomes.